ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,121, issued on Feb. 3, was assigned to Arizona Board of Regents on behalf of Arizona State University (Scottsdale, Ariz.).
"Compositions comprising a retinoid X receptor (RXR) agonist, a retinoic acid receptor (RAR) agonist, or a dual RXR/RAR agonist" was invented by Carl Wagner (Glendale, Ariz.), Pamela Marshall (Peoria, Ariz.) and Peter Jurutka (Scottsdale, Ariz.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions comprising an RXR agonist, an RAR agonist, or a dual RXR/RAR agonist. The present invention further relates to methods of using the agonist compositions for treating or preventing dementia and canc...